Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it ...

Under the nonbinding proposal, Bain Capital Private Equity would acquire the remaining shares of Surgery Partners it does not ...

Private equity firm Bain Capital plans to fully acquire Surgery Partners, one of the five largest operators of ambulatory surgery centers, for $3.2 billion.

Brookfield emerges as the third suitor for Insignia, also offering A$3.07 billion and sparking a three-way bidding war for the Aussie wealth manager. Copyright 2025 Thomson Reuters.

Bain Capital is closing in on its next big target struggling with too much debt – the country’s second-largest hospital operator Healthscope.

Private equity giant KKR (KKR) has upped its offer price for Japan-based IT company Fuji Soft in its ongoing complex takeover ...

U.S. private equity firm KKR will raise its tender offer price for Japanese IT company Fuji Soft to 9,850 yen a share from ...

Global healthcare private equity (PE) deal value surged to an estimated $115 billion in 2024, marking the second-highest ...

BAIN Capital is nearing a deal to buy Mitsubishi Chemical Group’s pharmaceutical unit, sources familiar with the matter said, ...

The US-based private equity firm and Mitsubishi are finalising details of a transaction that could be announced as soon as ...